Internal Medicine, Cardiovascular Disease · Austin, TX
NPI
1780617571
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1301 W 38th St, Suite 514
Austin, TX, 78705
Phone (512) 681-0500
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,136 services
Medicare patients, 2024
239
Average age 69
Drug cost, 2024
$4.4M
2,363 prescriptions
Company payments, 2025
$361
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernest A Haeusslein was code 99214 (office e&m - established), 218 times for 104 patients. In total Ernest A Haeusslein billed 1,136 services in 35 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 218 | 104 | $75.10 | $16K |
| 93306 Echocardiography (TTE/TEE) | Facility | 128 | 119 | $51.14 | $6,546 |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 51 | $99.26 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 122 | 71 | $13.58 | $1,656 |
| 93750 External Electrocardiographic Monitoring | Facility | 104 | 18 | $31.51 | $3,277 |
| 99232 Hospital E&M - Subsequent | Facility | 75 | 29 | $66.46 | $4,985 |
| 99291 Critical Care E&M | Facility | 55 | 20 | $178.11 | $9,796 |
| 99223 Hospital E&M - Initial | Facility | 37 | 33 | $145.94 | $5,400 |
| 99152 Anesthesia | Facility | 30 | 30 | $10.15 | $304 |
| 93000 Electrocardiogram | Facility | 26 | 23 | $11.44 | $297 |
| 99215 Office E&M - Established | Facility | 21 | 21 | $116.02 | $2,436 |
| 99213 Office E&M - Established | Facility | 21 | 15 | $50.37 | $1,058 |
| 94618 Pulmonary Function Testing | Facility | 19 | 17 | $15.21 | $289 |
| 99205 Office E&M - New | Facility | 17 | 17 | $125.58 | $2,135 |
| 93451 Percutaneous Transcatheterization | Facility | 16 | 16 | $100.83 | $1,613 |
By year: 2022 $75K for 1,045 services; 2023 $67K for 947 services; 2024 $77K for 1,136 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ernest A Haeusslein prescribed most often to Medicare patients was Potassium Chloride, with 153 prescriptions and refills. In total Ernest A Haeusslein wrote 2,363 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Chloride Generic | 153 | 365 | 41 | $3,783 |
| Furosemide Generic | 138 | 303 | 41 | $1,036 |
| Spironolactone Generic | 134 | 351 | 40 | $771 |
| Carvedilol Generic | 129 | 370 | 34 | $1,036 |
| Atorvastatin Calcium Generic | 117 | 307 | 38 | $921 |
| Torsemide Generic | 103 | 227 | 31 | $4,125 |
| Tadalafil Generic | 100 | 102 | 12 | $16K |
| Ambrisentan Generic | 94 | 100 | Under 11 | $414K |
| Entresto Sacubitril/Valsartan | 91 | 113 | 19 | $73K |
| Losartan Potassium Generic | 74 | 182 | 19 | $803 |
| Uptravi Selexipag | 73 | 73 | Under 11 | $1.8M |
| Rosuvastatin Calcium Generic | 71 | 167 | 16 | $467 |
| Metoprolol Succinate Generic | 69 | 157 | 23 | $865 |
| Adempas Riociguat | 66 | 66 | Under 11 | $879K |
| Warfarin Sodium Generic | 58 | 121 | 13 | $665 |
Brand drugs: - claims; generic drugs: 1,907 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernest A Haeusslein $361 ($361 in general payments such as food, travel and fees) from 4 companies. The largest payer was Ancora Heart, Inc. with $127.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.